ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Articles by P K RamachandranSubscribe to P K Ramachandran

Anomalies in Drug Prices and Quality Control

Anomalies in Drug Prices and Quality Control P S Agarwal P K Ramachandran B V Rangarao Drug price indices in the developed countries have been falling when static groups of drugs are considered, though for the industry as a whole the price indices have risen due to the discovery and introduction of new drugs. In India, however, the drug price index calculated on the basis of the prices of a static group of drugs had risen by 41.9 points by 1970-71 with 1961-62 as the base. The rise was sharp after 1965-66 which, by a remarkable coincidence, was also the period when the Government of India referred the costs and prices of a few selected drugs to the Tariff Commission for study. The highest annual increase of 12 points occurred in 1970-71 with the announcement of the Drug Prices Control Order.

The Pharmaceutical Industry in India

Though there are a large number of units in the Indian pharmaceutical industry, the core of the industry is dominated by multinational firms operating as Indian subsidiaries and by firms with foreign financial or technical participation. These firms greatly depend on imported technology and imported raw materials for production.
Back to Top